See also

References

1. ^Litschig S, Gasparini F, Rueegg D, Stoehr N, Flor PJ, Vranesic I, Prézeau L, Pin JP, Thomsen C, Kuhn R (March 1999). "CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding".Molecular Pharmacology.55 (3):453–61.PMID 10051528.
2. ^Ott D, Floersheim P, Inderbitzin W, Stoehr N, Francotte E, Lecis G, Richert P, Rihs G, Flor PJ, Kuhn R, Gasparini F (November 2000). "Chiral resolution, pharmacological characterization, and receptor docking of the noncompetitive mGlu1 receptor antagonist (+/-)-2-hydroxyimino- 1a, 2-dihydro-1H-7-oxacyclopropa[b]naphthalene-7a-carboxylic acid ethyl ester".Journal of Medicinal Chemistry.43 (23):4428–36.doi:10.1021/jm0009944.PMID 11087567.
3. ^Fukunaga I, Yeo CH, Batchelor AM (February 2007). "The mGlu1 antagonist CPCCOEt enhances the climbing fibre response in Purkinje neurones independently of glutamate receptors".Neuropharmacology.52 (2):450–8.doi:10.1016/j.neuropharm.2006.08.014.PMID 17045308.S2CID 40361285.
4. ^Sugiyama Y, Kawaguchi SY, Hirano T (February 2008). "mGluR1-mediated facilitation of long-term potentiation at inhibitory synapses on a cerebellar Purkinje neuron".The European Journal of Neuroscience.27 (4):884–96.doi:10.1111/j.1460-9568.2008.06063.x.PMID 18279362.S2CID 25581416.
5. ^Lominac KD, Kapasova Z, Hannun RA, Patterson C, Middaugh LD, Szumlinski KK (November 2006). "Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: potential insight into their anti-addictive properties".Drug and Alcohol Dependence.85 (2):142–56.doi:10.1016/j.drugalcdep.2006.04.003.PMID 16697125.
6. ^Kim J, Lee S, Park H, Song B, Hong I, Geum D, Shin K, Choi S (March 2007). "Blockade of amygdala metabotropic glutamate receptor subtype 1 impairs fear extinction".Biochemical and Biophysical Research Communications.355 (1):188–93.doi:10.1016/j.bbrc.2007.01.125.PMID 17292864.